Armistice Capital »

Manhattan Associates shares owned by Armistice Capital

Quarter-by-quarter ownership of Manhattan Associates (MANH) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Manhattan Associates

Tip: Access up to 7 years of quarterly data

All positions including Manhattan Associates held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Manhattan Associates by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $342k 1.7k 204.98

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Manhattan Associates

Vanguard Group
BlackRock
Alliancebernstein
FMR
Morgan Stanley
AQR Capital Management
T. Rowe Price Investment Management
State Street Corporation
Geode Capital Management
Kayne Anderson Rudnick Investment Management
Swedbank AB
Franklin Resources
Neuberger Berman Group
Invesco
Citadel Advisors

View all funds holding Manhattan Associates